Physiomics wins further contract with Bicycle Therapeutics

Oncology consultancy Physiomics revealed on Friday that it had been awarded a further contract by existing client Bicycle Therapeutics.

Physiomics stated the project related to an undisclosed program and was expected to be completed in the company's current financial year.

The AIM-listed group did not disclose the value of the contract.

Chief executive Dr Jim Millen said: "We are delighted that Bicycle has chosen us to support this new project. Physiomics has been working with Bicycle since 2019 and has been involved in various Bicycle programs spanning discovery through clinical development. We look forward to working with this valued client once again."

As of 0850 GMT, Physiomics shares were untraded at 4.20p.

Reporting by Iain Gilbert at Sharecast.com